Literature DB >> 25400782

Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience.

Yuping Gao1, Jiyao Jiang2, Qiang Liu3.   

Abstract

Primary central nervous system (CNS) germ cell tumors (GCTs) are a rare heterogeneous group of lesions, which the clinicopathological features have a marked degree of heterogeneity comparing with that of gonadal GCTs. Accurately diagnosing CNS GCTs might be extremely difficult and requires immunohistochemical verification. This study was to investigate the biological feature of CNS GCTs and diagnostic value of immunohistochemical markers OCT3/4, C-kit, PLAP, and CD30 in CNS GCTs. A retrospective study was performed on 34 patients with CNS germ cell tumors between 1990 and 2014. 34 CNS GCTs account for 9.2% of all primary CNS neoplasms. The sellar region (35.3%) and pineal gland (17.6%) were the most common sites of intracranial GCTs. Hydrocephalus (82.4%) and diplopia (46.9%) were the two most common clinical presentations. The most common histological subtypes were germinoma (67.6%). PLAP, c-kit, OCT3/4 were highly expressed in gernimomas. CD30 and CK AE1/3 stainings were positive in embryonal carcinoma. Yolk sac tumor component showed positive staining for AFP and CK AE1/3. β-HCG staining was positive in choriocarcinoma and STGC. Patients with mature teratomas and germinomas had a better prognosis (a 5-year survival rate) than those with embryonal carcinoma and choriocarcinoma (a 5-year survival rates were 0). Our finding suggest that the incidences of primary CNS GCTs are higher in South China than in the West, but mixed GCTs are uncommon in our study. The judicious use of a panel of selected markers is helpful in diagnosing and predicting the prognosis for CNS GCTs.

Entities:  

Keywords:  C-kit; CD30; Central nervous system; OCT3/4; PLAP; germ cell tumors

Mesh:

Substances:

Year:  2014        PMID: 25400782      PMCID: PMC4230147     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.

Authors:  L Cheng; M-T Sung; P Cossu-Rocca; T D Jones; G T MacLennan; J De Jong; A Lopez-Beltran; R Montironi; L H J Looijenga
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases.

Authors:  M Matsutani; K Sano; K Takakura; T Fujimaki; O Nakamura; N Funata; T Seto
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

3.  The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.

Authors:  AeRang Kim; Lingyun Ji; Casilda Balmaceda; Blanca Diez; Stewart J Kellie; Ira J Dunkel; Sharon L Gardner; Richard Sposto; Jonathan L Finlay
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

Review 4.  Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.

Authors:  Thomas M Ulbright
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

5.  CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome.

Authors:  Hiroyuki Ogino; Yuta Shibamoto; Tsuyoshi Takanaka; Kazunori Suzuki; Shun-Ichi Ishihara; Tetsuya Yamada; Chikao Sugie; Yoshihito Nomoto; Mikio Mimura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

6.  New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.

Authors:  C E Hoei-Hansen; A Sehested; M Juhler; Y-F C Lau; N E Skakkebaek; H Laursen; E Rajpert-de Meyts
Journal:  J Pathol       Date:  2006-05       Impact factor: 7.996

7.  Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.

Authors:  Masayuki Kanamori; Toshihiro Kumabe; Ryuta Saito; Yoji Yamashita; Yukihiko Sonoda; Hisanori Ariga; Yoshihiro Takai; Teiji Tominaga
Journal:  J Neurosurg Pediatr       Date:  2009-12       Impact factor: 2.375

8.  Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy.

Authors:  Yasuhiro Kawabata; Jun A Takahashi; Yoshiki Arakawa; Mitsuaki Shirahata; Nobuo Hashimoto
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

Review 9.  Pathogenesis of intracranial germ cell tumors reconsidered.

Authors:  K Sano
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

Review 10.  Intracranial germ-cell tumors: natural history and pathogenesis.

Authors:  M T Jennings; R Gelman; F Hochberg
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

View more
  11 in total

1.  Characteristics of growth disturbances in patients with intracranial germinomas of different origins.

Authors:  Bo Li; Jiayi Wang; Jiongxian Yang; Yanong Li; Yanwei Liu; Shuai Liu; Xiaoguang Qiu
Journal:  Childs Nerv Syst       Date:  2021-05-24       Impact factor: 1.475

2.  Loco-regional extensions of central nervous system germ cell tumors: a retrospective radiological analysis of 100 patients.

Authors:  Loïc Duron; Flavie Sadones; Philippe Thiesse; Cécile Cellier; Claire Alapetite; François Doz; Didier Frappaz; Hervé J Brisse
Journal:  Neuroradiology       Date:  2017-09-23       Impact factor: 2.804

3.  Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India.

Authors:  Aanchal Kakkar; Ahitgani Biswas; Nikhil Kalyani; Uttara Chatterjee; Vaishali Suri; Mehar C Sharma; Nishant Goyal; Bhawani S Sharma; Supriya Mallick; Pramod K Julka; Girish Chinnaswamy; Brijesh Arora; Epari Sridhar; Sandip Chatterjee; Rakesh Jalali; Chitra Sarkar
Journal:  Childs Nerv Syst       Date:  2016-07-30       Impact factor: 1.475

4.  Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.

Authors:  Jenny J Ko; Tehmina Asif; Haocheng Li; Nimira Alimohamed; Phuong Thao Nguyen; Daniel Y C Heng
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

5.  Germinoma with an extensive rhabdoid cell component centered at the corpus callosum.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Med Mol Morphol       Date:  2015-05-27       Impact factor: 2.309

6.  Primary Central Nervous System Germ Cell Tumors: A Review and Update.

Authors:  Kaleigh Fetcko; Mahua Dey
Journal:  Med Res Arch       Date:  2018-03-15

7.  Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.

Authors:  Holly Lindsay; Yulun Huang; Yuchen Du; Frank K Braun; Wan Yee Teo; Mari Kogiso; Lin Qi; Huiyuan Zhang; Sibo Zhao; Hua Mao; Frank Lin; Patricia Baxter; Jack M Su; Keita Terashima; Laszlo Perlaky; Murali Chintagumpala; Adekunle Adesina; Ching C Lau; D Williams Parsons; Xiao-Nan Li
Journal:  J Neurooncol       Date:  2016-03-08       Impact factor: 4.130

8.  Emergency irradiation with 3.4 Gy/2f in sellar/suprasellar germinoma patients with rapid visual acuity decline.

Authors:  Bo Li; You-Qi Li; Chun-De Li; Yao Chen; Yan-Wei Liu; Shuai Liu; Xiao-Guang Qiu; Shi-Qi Luo
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

9.  Comparison between Craniospinal Irradiation and Limited-Field Radiation in Patients with Non-metastatic Bifocal Germinoma.

Authors:  Bo Li; Wenyi Lv; Chunde Li; Jiongxian Yang; Jiajia Chen; Jin Feng; Li Chen; Zhenyu Ma; Youqi Li; Jiayi Wang; Yanwei Liu; Yanong Li; Shuai Liu; Shiqi Luo; Xiaoguang Qiu
Journal:  Cancer Res Treat       Date:  2020-07-09       Impact factor: 4.679

10.  A rare giant mixed germ cell tumor of the pineal region with immature elements: Case report and review of the literature.

Authors:  Camille K Milton; Panayiotis E Pelargos; Nathaniel D Stetson; Manuel Maldonado-Vital; Kar-Ming A Fung; Ian F Dunn
Journal:  Rare Tumors       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.